536 related articles for article (PubMed ID: 22858156)
21. Resveratrol suppresses angiogenesis in gliomas: evaluation by color Doppler ultrasound.
Chen JC; Chen Y; Lin JH; Wu JM; Tseng SH
Anticancer Res; 2006; 26(2A):1237-45. PubMed ID: 16619530
[TBL] [Abstract][Full Text] [Related]
22. Angiogenesis and invasion in glioma.
Onishi M; Ichikawa T; Kurozumi K; Date I
Brain Tumor Pathol; 2011 Feb; 28(1):13-24. PubMed ID: 21221826
[TBL] [Abstract][Full Text] [Related]
23. Anti-angiogenic approaches to malignant gliomas.
Soffietti R; Trevisan E; Bertero L; Bosa C; Ruda R
Curr Cancer Drug Targets; 2012 Mar; 12(3):279-88. PubMed ID: 22229250
[TBL] [Abstract][Full Text] [Related]
24. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
25. Dexamethasone alleviates tumor-associated brain damage and angiogenesis.
Fan Z; Sehm T; Rauh M; Buchfelder M; Eyupoglu IY; Savaskan NE
PLoS One; 2014; 9(4):e93264. PubMed ID: 24714627
[TBL] [Abstract][Full Text] [Related]
26. [Anti-angiogenesis treatment for brain tumors: present and future].
Takano S; Matsumura A
No Shinkei Geka; 2006 Jul; 34(7):657-78. PubMed ID: 16841703
[No Abstract] [Full Text] [Related]
27. Bevacizumab in high-grade gliomas: past, present, and future.
Curry RC; Dahiya S; Alva Venur V; Raizer JJ; Ahluwalia MS
Expert Rev Anticancer Ther; 2015 Apr; 15(4):387-97. PubMed ID: 25797685
[TBL] [Abstract][Full Text] [Related]
28. PTK787/ZK222584, an inhibitor of vascular endothelial growth factor receptor tyrosine kinases, decreases glioma growth and vascularization.
Goldbrunner RH; Bendszus M; Wood J; Kiderlen M; Sasaki M; Tonn JC
Neurosurgery; 2004 Aug; 55(2):426-32; discussion 432. PubMed ID: 15271251
[TBL] [Abstract][Full Text] [Related]
29. Angiogenesis and antiangiogenic therapy for malignant gliomas.
Takano S; Kamiyama H; Tsuboi K; Matsumura A
Brain Tumor Pathol; 2004; 21(2):69-73. PubMed ID: 15700836
[TBL] [Abstract][Full Text] [Related]
30. Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis.
Koga K; Todaka T; Morioka M; Hamada J; Kai Y; Yano S; Okamura A; Takakura N; Suda T; Ushio Y
Cancer Res; 2001 Aug; 61(16):6248-54. PubMed ID: 11507079
[TBL] [Abstract][Full Text] [Related]
31. Antiangiogenesis: biology and utility in the treatment of gliomas.
Chamberlain MC
Expert Rev Neurother; 2008 Oct; 8(10):1419-23. PubMed ID: 18928336
[No Abstract] [Full Text] [Related]
32. Translational emphasis: hypoxia and vasculogenesis in glioma recurrence.
Neman J; Jandial R
Neurosurgery; 2010 Jun; 66(6):N20-1. PubMed ID: 20495415
[No Abstract] [Full Text] [Related]
33. NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment.
Broggini T; Wüstner M; Harms C; Stange L; Blaes J; Thomé C; Harms U; Mueller S; Weiler M; Wick W; Vajkoczy P; Czabanka M
Cancer Lett; 2016 Oct; 380(2):568-576. PubMed ID: 26297987
[TBL] [Abstract][Full Text] [Related]
34. Antiangiogenic therapy in malignant glioma: promise and challenge.
Sathornsumetee S; Rich JN
Curr Pharm Des; 2007; 13(35):3545-58. PubMed ID: 18220791
[TBL] [Abstract][Full Text] [Related]
35. Targeting glioma stem cells: a novel framework for brain tumors.
Binello E; Germano IM
Cancer Sci; 2011 Nov; 102(11):1958-66. PubMed ID: 21848914
[TBL] [Abstract][Full Text] [Related]
36. Glioma stem cells and their roles within the hypoxic tumor microenvironment.
Boyd NH; Tran AN; Bernstock JD; Etminan T; Jones AB; Gillespie GY; Friedman GK; Hjelmeland AB
Theranostics; 2021; 11(2):665-683. PubMed ID: 33391498
[TBL] [Abstract][Full Text] [Related]
37. Complementary information from magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model.
Valable S; Petit E; Roussel S; Marteau L; Toutain J; Divoux D; Sobrio F; Delamare J; Barré L; Bernaudin M
Nucl Med Biol; 2011 Aug; 38(6):781-93. PubMed ID: 21843775
[TBL] [Abstract][Full Text] [Related]
38. Visualization of rodent brain tumor angiogenesis and effects of antiangiogenic treatment using 3D ΔR2-μMRA.
Lin CY; Siow TY; Lin MH; Hsu YH; Tung YY; Jang T; Recht L; Chang C
Angiogenesis; 2013 Oct; 16(4):785-93. PubMed ID: 23736837
[TBL] [Abstract][Full Text] [Related]
39. Angiogenesis in gliomas: imaging and experimental therapeutics.
Gagner JP; Law M; Fischer I; Newcomb EW; Zagzag D
Brain Pathol; 2005 Oct; 15(4):342-63. PubMed ID: 16389946
[TBL] [Abstract][Full Text] [Related]
40. iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas.
Kang T; Gao X; Hu Q; Jiang D; Feng X; Zhang X; Song Q; Yao L; Huang M; Jiang X; Pang Z; Chen H; Chen J
Biomaterials; 2014 May; 35(14):4319-32. PubMed ID: 24565520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
